Roquefort Therapeutics is acquiring exclusive worldwide rights to a clinical-stage tumour inhibitor for £32m in an all-paper ...

Telix shares surge as much as 14% after its most advanced cancer therapy candidate passes phase III safety and dosimetry hurdles Clarity says it will achieve the targeted 220 patients for its prostate ...

THOMASVILLE — Archbold Urology is committed to offering patients in the region access to the most advanced treatments for urologic conditions that affect many of its neighbors.

Dr Marc Laniado made a choice to be more mindful of his own health - here's what he discovered, from 'exercise snacking' to ...

Let's see what this radiopharmaceuticals company has announced this morning. The post Telix shares jump 14% on big news appeared first on The Motley Fool Australia.

MELBOURNE, Australia and INDIANAPOLIS, March 10, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces ...

Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ...

Nurses and advanced practice registered nurses (APRNs) play a central role in preventive care, screening, chronic disease management, and patient education. Expanding this workforce is particularly ...

The neuroendocrine carcinoma market is experiencing steady growth driven by rising disease prevalence and improved diagnostic capabilities. Advancements in targeted therapies and immunotherapies ...

Incidental detection has increased with ubiquitous CT/MRI, inflating early-stage ‘small renal mass’ diagnoses and complicating interpretation of a ~5% rise in <50-year incidence. Obesity, hypertension ...

Shares rebound from Monday’s $90b wipeout; oil back to $US90 after earlier surge toward $120; Fortescue completes Alta buy; Air New Zealand axes guidance over conflict. Follow live.

As the world marks International Women’s Day, her story highlights both the resilience of women and the urgent need for greater awareness around cancer screening and support.